Status:
COMPLETED
Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study
Lead Sponsor:
Mclean Hospital
Conditions:
Bipolar Disorder
Mania
Eligibility:
All Genders
18-68 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine whether the amino acid taurine has effects on mood stability in bipolar disorder.
Detailed Description
Taurine is an amino acid that has some actions similar to mood stabilizers. Taurine is widely sold as a component of over-the-counter mood enhancing agents. However, controlled studies examining the m...
Eligibility Criteria
Inclusion
- bipolar disorder, type I bipolar disorder, type II mania hypomania mixed manic symptoms
Exclusion
- significant medical or psychiatric co-morbidity pregnancy or planning pregnancy current substance abuse or dependence
- \-
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00217165
Start Date
April 1 2005
End Date
December 1 2011
Last Update
March 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McLean Hospital
Belmont, Massachusetts, United States, 02478